Actively Recruiting
A Phase I Study to Evaluate LIFE-001
Led by LifeMine Therapeutics · Updated on 2026-03-19
150
Participants Needed
1
Research Sites
83 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if LIFE-001 is safe and tolerable for healthy adult volunteers.
CONDITIONS
Official Title
A Phase I Study to Evaluate LIFE-001
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female or male between the ages of 18 and 65 years, inclusive
- Medically healthy (without significant medical issues, e.g. high blood pressure)
- Must provide written informed consent
You will not qualify if you...
- Ongoing or history of any psychiatric, medical or surgical condition that might jeopardize the participant's safety or interfere with the absorption, distribution or excretion of the study drug
- Any abnormal ECG findings, laboratory value or physical examination findings
- Positive ethanol, drug screen or cotinine test
- Use of systemic prescription medications or over-the-counter (OTC) medication, including multivitamins, and dietary and herbal supplement within 7 days
- Use of any experimental or investigational device within 30 days
- Donation or loss of 500 mL or more of blood within 30 weeks and/or donation of plasma within 30 days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Veritus Research Pty Ltd
Bayswater, Victoria, Australia, 3163
Actively Recruiting
Research Team
S
Simon Cooper
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here